ICYMI, Weekly Stock Market Recap. Sept 17-21


22-Sep-2018 10:19 AM



In case you missed this week stock market movers news. This is our weekly recap.

Monday Down Jones down -92.55 points, SPY-0.53%, QQQ -1.44%, IWM -1.06%, IBB -1.32%.  POTUS

  • TG Therapeutics Inc (TGTX) stock down -11.63% for the day due to no specific date for data announcement
  • (AMZN) stock down -3.15% on reports of employee data leaks to sellers on site by deleting negative reviews.
  • Teva Pharmaceuticals Industries Ltd (TEVA) FDA approves AJOVYTM injection.  Stock up +2.54%
  • Mersana Therapeutics Inc (MRNS) partial hold XMT-1522  being lifted by  FDA. Stock down -22.53%

Tuesday the US stock market shake off the 10% of $200 billion tariffs imposed by the POTUS. Dow Jones up +185.04 points, SPY +0.55%, IBB +1.12%, IWM +0.41%, QQQ +0.83%

  • Viking Therapeutics Inc (VKTX) the study VK2809 succeed in a mid-stage trial. Stock up +87.30% for the day.
  • Tesla Inc (TSLA) stock dropped midday due to news from Bloomberg that CEO has been criminal probe to the "Secure Funding" tweet early last month. Stock down -3.35%
  • Tilray Inc (TLRY)  The Fear Of Missing Out #FOMO stock up +26.88%

Wednesday financial sector leading the market rallies., and China ADRs stocks relief bounce.  Dow Jones up +158.80 points, SPY +0.11%, QQQ-0.08%, IWM -0.36%, IBB +0.13%.

  • Tilray, Inc (TLRY) continue the #FOMO rallies up +70% intraday then stock halted and back down to finished up +38.12%
  • Baidu Inc (BIDU)  stock up+4.39%
  • Alibaba Group Holding Ltd (BABA) stock up +3.82%
  • Altimmune Inc (ALT) low floater top percentage gainers for the day +272.54%

Thursday third day the US stock market rallies, NASDAQ post new all-time high, Dow Jones +251.49 points, SPY +0.79%, QQQ +1.11%, IWM +0.93%, IBB +1.39%

  • Corbus Pharmaceuticals Holdings, Inc (CRBP) stock rallies ahead of Jim Cramer to interview the CEO
  • NVIDIA Corp (NVDA)  from Morgan Stanley analyst expect Turing ramp may be 'slow and steady', stock trade down
  • Acadian Pharmaceuticals Inc (ACAD) the FDA finds no new or unexpected safety risks for Nuplazid

Friday Dow Jones finished on record week.

  • GTX Inc (GTXI) Phase 2 trial ASTRID did not meet the primary endpoint, stock down -92.27%
  • Kalvista Pharmaceuticals Inc (KALV) new 52 weeks high at $20.98
  • Tilray Inc (TLRY) after the stock hit $300 earlier this week, end close at $123.00

Friday after hours news China calls off the trade talks, won't go to Washington. 

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.